Authors/Disclosures
|
|
No disclosure on file |
|
Sara Shanske, PhD
(Colombia College Physician &)
|
No disclosure on file |
|
Jorida Coku
|
No disclosure on file |
|
Carlos A. Luciano, MD, FAAN
(University of Puerto Rico School of Medicine)
|
Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea Pharmaceuticals. Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SIMED. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Universal Insurance Co.. Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pueblo Supermarket. The institution of Dr. Luciano has received research support from National Institutes of Health. The institution of Dr. Luciano has received research support from Catalyst Pharmaceuticals. Dr. Luciano has received personal compensation in the range of $100,000-$499,999 for serving as a Professor and Chair with University of Puerto Rico. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Stephen J. Howell, BS, EMT-B
|
Mr. Howell has nothing to disclose. |
|
Salvatore DiMauro, MD
(Columbia University Medical Center)
|
No disclosure on file |
|
Michio Hirano, MD, FAAN
(Columbia University Medical Center)
|
Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for 好色先生. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. Dr. Hirano has received research support from Reneo Pharmaceuticals. The institution of Dr. Hirano has received research support from Astellas. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities. |